UCB SA (UCBJF)
OTCMKTS · Delayed Price · Currency is USD
290.00
-4.18 (-1.42%)
At close: Oct 2, 2025
UCB SA Market Cap
UCB SA has a market cap or net worth of $54.77 billion as of October 3, 2025. Its market cap has increased by 54.13% in one year.
Market Cap
54.77B
Enterprise Value
56.26B
Revenue
8.04B
Ranking
n/a
PE Ratio
35.01
Stock Price
$290.00
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 1.20B to 54.77B, an increase of 4,461.94%. That is a compound annual growth rate of 13.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 54.77B | 45.09% |
| Dec 31, 2024 | 37.75B | 128.16% |
| Dec 29, 2023 | 16.55B | 10.80% |
| Dec 30, 2022 | 14.93B | -30.70% |
| Dec 31, 2021 | 21.55B | 10.36% |
| Dec 31, 2020 | 19.53B | 30.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Tian'an Technology Group | 718.73M |
| Elite Pharmaceuticals | 687.00M |
| Glass House Brands | 598.71M |
| Northwest Biotherapeutics | 364.70M |
| CytoDyn | 326.79M |
| Nika Pharmaceuticals | 301.74M |
| American Oncology Network | 273.17M |